common in elderly patients with HCM caused by sarcomere gene mutations. We reevaluated the morphologic features of HCM in elderly patients with mutations in the cardiac myosin-binding protein C (MyBPC) gene, the most common genetic cause of HCM in the elderly. 11 
Methods

Subjects
The study subjects comprised 109 patients with HCM from Kochi prefecture in southwestern Japan who were evaluated at the Kochi Medical School. The diagnosis of HCM was based on 2-dimensional echocardiographic demonstration of unexplained LVH (wall thickness ≥15 mm) without systemic hypertension or another intrinsic cardiac or systemic disease capable of producing that magnitude of wall thickening. Individuals with LV systolic dysfunction (end-stage HCM) or apical HCM were excluded because they were not suitable for analysis of LV morphology. Written informed consent was given by all subjects in accordance with the guidelines of the Ethics Committee on Medical Research at Kochi Medical School. 15 Finally, 65 patients were enrolled for clinical evaluation and genetic testing. bution of LVH were also assessed using 2-dimensional images and indices as previously described. 17, 18 In the parasternal short-axis plane, the LV was divided into 4 segments: anterior and posterior ventricular septum, and anterolateral and posterior free wall. The greatest wall thickness measured at any site in the LV wall was regarded as the maximal thickness, independent of correction for body surface area, gender, or age. Right ventricular wall thickness was evaluated in the parasternal long-axis view, and a wall thickness of more than 5 mm was defined as hypertrophy. The peak instantaneous LV outflow pressure gradient was estimated by continuous-wave Doppler under basal conditions. A LV outflow gradient ≥30 mmHg was considered significant. Wigle score was also calculated as previously reported. 19 Furthermore, we studied the morphologic features according to the report by Lever et al. 12 In brief, (1) septal curvature was evaluated in the apical 4-chamber view (Fig 1) . An abnormal convexity of the septum toward the LV cavity was defined as reversed septal curvature, which produced a crescent-shaped LV cavity. Slight concavity toward the LV cavity or a more straight septal contour was considered as normal septal curvature. The latter produced an ovoid LV cavity. (2) Proximal septal bulge was assessed in the parasternal long-axis and apical 4-chamber views, and was defined as a subaortic protuberance of the septum toward the LV outflow tract (LVOT) with the middle and distal septum having normal shape. (3) Mitral annular calcification was also evaluated as an increased echocardiographic density of the mitral annulus.
Genetic Analysis
Peripheral blood samples were taken at the time of clinical evaluation, and they were frozen and stored at -20°C. 15 Deoxyribonucleic acid (DNA) was extracted using a DNA purification kit (No. 51104; Qiagen Inc, Hilden, Germany). In vitro amplification of genomic DNA was performed using the polymerase chain reaction (PCR). Oligonucleotide primers were used to amplify protein-encoding exons of MyBPC. (Information on primer sequences and PCR conditions is available upon request.) Sequencing was performed using a BigDye Terminator Cycle Sequencing Kit (No. 4336774; Applied Biosystems, Foster City, CA, USA). The sequences were analyzed on an ABI PRISM 3100-Avant Genetic Analyzer in accordance with the manufacturer's instructions. In patients in whom mutation was identified, confirmation was obtained by re-analysis with direct sequencing from a second blood sample.
Clinical Findings
Functional class was based upon the New York Heart Association (NYHA) classification. Patients with hypertension were defined as those with blood pressure greater than 140/85 mmHg or those taking anti-hypertensive drugs other than -blocker and/or calcium antagonist. Electrocardiograms were evaluated for cardiac rhythm, SV1 + RV5 ≥35 mm as LVH, and presence of giant negative T waves as defined by a depth of ≥10 mm in the left precordial leads.
Statistical Analysis
All data are presented as mean ± SD. Student's t-test was used to compare mean values between 2 groups. The 2 test was also used to compare contingency table data. For tables with small excepted cell frequencies, Fisher's exact test was used. A p-value <0.05 was considered statistically significant.
Results
Patient Characteristics
Baseline characteristics and echocardiographic findings of all patients are shown in Tables 1 and 2 , respectively. The prevalence of an ovoid-shaped LV was higher in the elderly patients (≥65 years old) than in the young patients (<65 years old) (38% vs 19%, p=0.09).
Among the 65 patients, 27 were identified with mutations in MyBPC and a positive phenotype was defined as a hypertrophied, non-dilated LV. The mutations in MyBPC were V592fs/8 (frameshift mutation: a 1-base deletion of a thymidine at nucleotide 11645) in 23 patients, S297X (nonsense mutation: a cytosine to guanine transversion at nucleotide 6239) in 4 patients, and R945fs/105 (frameshift mutation: a 2-base deletion of a cytosine and guanine at nucleotides 18535 and 18536) in 1 patient. Two of the 3 mutations (V592fs/8 and R945fs/105) have previously been described as disease-causing mutations 15, 20, 21 and one mutation (S297X) was novel. These mutations are thought to be disease-causing based on the presence of the mutation in all affected relatives and the absence of the sequence variation in at least 200 chromosomes from healthy individuals. Patients with mutations in MyBPC were younger than those without (54±16 years old vs 64±14 years old, p=0.007). On the other hand, the prevalence of a family history of HCM was more common in patients with a mutation in MyBPC than in those without mutation (67% vs 16%, p<0.0001).
The patients with mutations in MyBPC were divided into 2 groups according to age ( Table 1) . The elderly patients ranged in age from 65 to 83 years (mean 73±7 years, n=8) and the young patients ranged in age from 28 to 61 years (mean 45±11 years, n=19). There was no significant difference in NYHA functional class between the 2 groups and most patients showed no or only mild symptoms. The prevalence of atrial fibrillation and systemic hypertension was significantly higher in the elderly patients than in the young patients. There was no significant difference in the treatment between the 2 groups.
Echocardiographic Findings
LV Wall Thickness and Dimensions (Table 2 ) Maximum LV wall thickness in the elderly patients ranged from 16 to 22 mm (mean 18±2 mm), and none of them showed extreme LVH (≥30 mm). Maximum LV wall thickness in the young patients was greater (range 17-38 mm, mean 24±6 mm), and 2 young patients showed extreme LVH. Distribution of LVH was predominantly diffuse (ie, in- volving ≥2 LV segments) in both the elderly and young patients. Wigle score was smaller in the elderly patients than in the young patients. Thus, LVH was significantly greater in the young than in the elderly for maximum LV wall thickness, Wigle score, and also interventricular septal thickness (22±5 mm vs 17±3 mm). LV and left atrial dimensions were larger in the elderly patients than in the young patients, and LV systolic function as assessed by % fractional shortening was reduced in the elderly patients compared with the young patients.
A significant LVOT gradient at rest (≥30 mmHg) was not present in the elderly patients, but was present in 4 young patients.
Morphologic Characteristics (Table 3) A distinct crescent-shaped LV cavity, with reversed septal curvature, was prominent in both groups (ie, 7 (75%) in the elderly and 18 (95%) in the young). An ovoid-shaped LV cavity, with normal septal curvature, was not frequent in either group (ie, 2 (25%) in the elderly and 1 (5%) in the young). Thus, there was no significant difference in the LV shape (crescent vs ovoid) between the 2 groups (Fig 1) . Also, none of the elderly patients showed a proximal septal bulge. Right ventricular hypertrophy was predominantly seen in the young patients and mitral annular calcification was common in the elderly patients. Fig 2 shows an apical 4-chamber view by echocardiography in an 83-year-old female. Abnormal convexity of the septum toward the LV cavity was defined as reversed septal curvature, which produced a crescent-shaped LV cavity in addition to a large left atrium.
Discussion
The results of this study indicate that the previously reported morphologic characteristics of HCM in elderly patients, such as an ovoid-shaped LV cavity and a proximal septal bulge, are not common in the elderly patients with HCM definitely caused by mutations in MyBPC. Moreover, a crescent-shaped LV cavity, which has been reported as the hallmark of HCM in young patients, is predominantly present in both elderly and young patients with HCM caused by mutations in MyBPC.
Etiology of HCM in the Elderly
HCM was originally described as a primary myocardial disease that showed significant LVH in the absence of other cardiovascular and systemic diseases capable of producing that magnitude of hypertrophy. Over the past decade, molecular genetic approaches have demonstrated that the main cause of HCM is sarcomere protein gene mutations. 1,2,7-10,15,20-22 However, a previous study 11 reported that elderly-onset HCM showed low positive mutations in sarcomere genes; among 31 patients diagnosed with lateonset HCM who had no known affected relatives, only 7 (23%) had mutations in the sarcomere genes (4 in MyBPC, 2 in cardiac troponin I, and 1 in -cardiac myosin heavy chain). Gene mutations were not identified in the remaining 24 patients (77%) and the cause of LVH in this group remained unknown. Nevertheless, the molecular basis for some elderly-onset disease indicates that this condition could be a heritable disorder of contractile proteins. The distribution of mutations in HCM of the elderly is strikingly different from that of early-onset HCM. Mutations in MyBPC were reported as the most frequent cause of HCM of the elderly 11 and indeed those mutations were the most frequent in our cohort. 15 Therefore, those are the reason why we specifically analyzed MyBPC in our present study and 27 patients were identified with mutations. Two of the 3 mutations (V592fs/8 and R945fs/105) have previously been described as disease-causing mutations 15, 20, 21 and one mutation (S297X) was new. This nonsense mutation is predicted to result in truncation of the protein. The mutation was present in all affected individuals (data for familial information are available upon request) and absent in at least 200 chromosomes from healthy individuals. Therefore, we concluded this mutation is disease-causing. There were 8 elderly (≥65 years) and 19 young (<65 years) patients, and they were compared for morphologic evaluation.
Morphologic Characteristics of HCM in the Elderly
Earlier studies have shown several distinct morphologic characteristics of HCM in the elderly. 5, [12] [13] [14] They reportedly show more predominantly an ovoid LV cavity contour with normal septal curvature, a proximal septal bulge, and mitral 12 In addition, the prevalence of a proximal septal bulge and mitral annular calcification was higher in the elderly patients than that in the young patients. Lewis et al reported that obstruction in the small LVOT was frequent in the elderly, in addition to an ovoid-shaped LV cavity. 13, 14 However, because of the lack of gene testing, it is possible that patients with heterogeneous causes of HCM or agerelated changes were included. In the present study, previously described morphologic characteristics of HCM in the elderly, particularly an ovoid-shaped LV cavity, were not common in elderly patients with HCM caused by mutations in MyBPC. A distinct crescent-shaped LV cavity with reversed septal curvature, which was frequently seen in the young patients (95%), was also prominent in the elderly patients (75%). Also, none of the elderly patients showed a proximal septal bulge. Thus, there was no significant difference between the elderly and young patients in the LV shape.
The results of this study are distinctly different from those of studies carried out before gene testing became available. For the purpose of the present study, elderly patients with HCM caused by mutation in MyBPC were enrolled. Therefore, although the morphologic features in patients with HCM caused by other sarcomere gene mutations are unresolved, a crescent-shaped LV in elderly patients with LVH suggests 'true' HCM caused by mutations in MyBPC rather than hypertensive hypertrophy or agerelated changes. 5,23.24 
Clinical Implication
In the clinical situation, the diagnosis of LVH or mild hypertension in the elderly patient is difficult and thus the shape of the LV may be useful for defining the etiology and therefore lead to prompt management.
Study Limitations
First; the number of study patients was small. Second, gene testing was performed only for mutations of MyBPC and other genes encoding sarcomeric proteins were not analyzed, leaving the possibility that the elderly patients in the previous reports had mutations in other genes. Further examination of elderly patients with HCM caused by other gene mutations is needed.
